IL6 and systemic sclerosis: Recent experimental and clinical data support the pivotal role of inflammatory cytokines as interleukin (IL)-1 and IL-6 in mechanisms of heart inflammation and cardiac dysfunction in several heart diseases (including SSc), and its potential role in the inflammation-driven pathway to myocardial fibrosis.